Scarica l'app Stockscreener
332.03
2.54%
-8.66
Dopo l'orario di chiusura:
332.00
-0.03
-0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ISRG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$340.69
Aprire:
$338.5
Volume 24 ore:
4.18M
Relative Volume:
1.47
Capitalizzazione di mercato:
$118.96B
Reddito:
$11.03B
Utile/perdita netta:
$3.16B
Rapporto P/E:
38.05
EPS:
8.7254
Flusso di cassa netto:
$2.83B
1 W Prestazione:
-17.47%
1M Prestazione:
-17.65%
6M Prestazione:
-36.63%
1 anno Prestazione:
-33.85%
Intervallo 1D:
$328.57
$340.55
Intervallo di 1 settimana:
$328.57
$367.74
Portata 52W:
$328.57
$603.88
Intuitive Surgical Inc Stock (ISRG) Company Profile
Nome
Intuitive Surgical Inc
Settore
Industria
Telefono
(408) 523-2100
Indirizzo
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ISRG
Intuitive Surgical Inc
|
332.03 | 122.06B | 11.03B | 3.16B | 2.83B | 8.7254 |
BDX
Becton Dickinson Co
|
153.00 | 42.20B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.19 | 32.85B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.63 | 31.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
191.91 | 27.98B | 5.54B | 1.52B | 1.74B | 10.37 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-07-23 | Downgrade | Erste Group | Buy → Hold |
| 2025-06-09 | Downgrade | Deutsche Bank | Hold → Sell |
| 2025-06-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-02 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2024-07-10 | Reiterato | Citigroup | Buy |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-11-17 | Iniziato | HSBC Securities | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-04-19 | Reiterato | BTIG Research | Buy |
| 2023-04-19 | Reiterato | BofA Securities | Buy |
| 2023-04-19 | Reiterato | Citigroup | Buy |
| 2023-04-19 | Reiterato | Evercore ISI | In-line |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2023-04-19 | Reiterato | Raymond James | Outperform |
| 2023-04-19 | Reiterato | Stifel | Buy |
| 2023-04-19 | Reiterato | Truist | Buy |
| 2023-04-19 | Reiterato | Wells Fargo | Overweight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-03-23 | Iniziato | William Blair | Outperform |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-13 | Iniziato | Mizuho | Neutral |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-04-13 | Iniziato | Truist | Buy |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2022-03-25 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-01-25 | Downgrade | Redburn | Buy → Neutral |
| 2022-01-21 | Reiterato | BTIG Research | Buy |
| 2022-01-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Evercore ISI | In-line |
| 2022-01-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-01-21 | Reiterato | Piper Sandler | Neutral |
| 2022-01-21 | Reiterato | Raymond James | Outperform |
| 2022-01-21 | Reiterato | Robert W. Baird | Outperform |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Reiterato | UBS | Neutral |
| 2022-01-21 | Reiterato | Wells Fargo | Overweight |
| 2022-01-10 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2021-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2021-07-21 | Reiterato | BofA Securities | Neutral |
| 2021-07-21 | Reiterato | Citigroup | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-07-21 | Reiterato | Piper Sandler | Neutral |
| 2021-07-21 | Reiterato | SVB Leerink | Mkt Perform |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-07-21 | Reiterato | UBS | Neutral |
| 2021-07-21 | Reiterato | Wells Fargo | Overweight |
| 2021-07-14 | Reiterato | Goldman | Buy |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-04-21 | Aggiornamento | Oppenheimer | Underperform → Perform |
| 2021-04-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2020-12-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-09-28 | Iniziato | Argus | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-07-20 | Reiterato | Bernstein | Outperform |
| 2020-04-28 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-17 | Downgrade | CFRA | Hold → Sell |
| 2020-04-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-09 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-04-01 | Downgrade | Oppenheimer | Perform → Underperform |
| 2020-01-27 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-12-12 | Reiterato | Wells Fargo | Outperform |
| 2019-11-21 | Iniziato | Oppenheimer | Perform |
| 2019-07-19 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-22 | Reiterato | Canaccord Genuity | Buy |
| 2019-04-02 | Iniziato | Deutsche Bank | Buy |
| 2018-10-31 | Reiterato | Piper Jaffray | Overweight |
| 2018-10-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
Mostra tutto
Intuitive Surgical Inc Borsa (ISRG) Ultime notizie
The Zacks Analyst Blog Highlights Qualcomm, Intuitive Surgical, Stryker, Frequency Electronics and Good Times Restaurants - Yahoo! Finance Canada
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It? - Yahoo Finance
Intuitive showcases AI for surgical robotics, telesurgery capabilities - MassDevice
Intuitive Shares Vision for an AI-Enabled Future of Healthcare - GlobeNewswire
FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’ - Fierce Biotech
Intuitive Surgical Confronts Rising Risks From Unauthorized da Vinci and Ion Parts and Service - TipRanks
Why Did PEGA, ISRG, MCD Stocks Plunge To 52-Week Lows Today? - Stocktwits
Johnson & Johnson announces its entry into the US robotic surgery market, says it is ready to enter hospi - The Times of India
Intuitive Surgical stock trades steadily as da Vinci procedures grow and margins expand - Ad-hoc-news.de
Top Stock Reports for Qualcomm, Intuitive Surgical & Stryker - Yahoo Finance
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Why Johnson & Johnson Is Sending Intuitive Surgical (ISRG) Stock Down Today - Barchart.com
Time runs out for Vicarious Surgical - MedTech Dive
The Wait Is Over: J&J's OTTAVA Surgical Robot Wins FDA Nod, Challenging Intuitive's 80% Market Share - Medical Device and Diagnostic industry
Intuitive Surgical (ISRG) investment analysis: fundamentals vs. technicals after the selloff By Investing.com - Investing.com
Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Johnson & Johnson Enters Robotic Surgery Market; Flagship Device Gets FDA Nod - NDTV Profit
Intuitive Surgical stock hits 52-week low at 342.06 USD By Investing.com - Investing.com South Africa
Intuitive Surgical stock hits 52-week low at 342.06 USD - Investing.com India
Intuitive Surgical, Medtronic down as J&J wins FDA nod for surgical robot - Seeking Alpha
ISRG Growth Story Hinges on Da Vinci 5, Ion and Recurring Revenue - TradingView
ISRG Trends Point to AI, Lung Biopsy Growth and Margin Pressure - TradingView
Is ISRG Stock Worth Buying as Growth Stays Strong but Risks Rise - TradingView
J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive - MedTech Dive
J&J MedTech jumps into surgical robot game as OTTAVA secures FDA nod - Medical Device Network
Can ISRG Maintain Its Premium Valuation Amid Slower Procedure Growth? - Yahoo Finance
J&J enters US robotic surgery market after device gets marketing authorization - Reuters
CICC Adjusts Intuitive Surgical Price Target to $389 From $501, Maintains Neutral Rating - marketscreener.com
Conmed’s AirSeal Robotic Solution OK’ed for Intuitive da Vinci 5 Hex Cannula - Medical Product Outsourcing
Johnson & Johnson wins FDA nod for Ottava surgical robot - MassDevice
CONMED Corporation Announces Expanded Indication for the FDA Cleared AirSeal - Business Wire
Even the da Vinci Surgical Robot Has Started to Reduce Costs - 36 Kr
ISRG SWOT Analysis: Strong Financials and Growth Potential Revea - GuruFocus
Intuitive Surgical (ISRG) Files $1.77 Billion ESOP Shelf Registration - simplywall.st
Intuitive Surgical Inc. stock underperforms Friday when compared to competitors - MSN
Intuitive Surgical Inc Q2 2026: Revenue $2.89B, EPS $2.29— 10-Q Summary - TradingView
[10-Q] INTUITIVE SURGICAL INC Quarterly Earnings Report - Stock Titan
Is Intuitive Surgical a Buy After Its Latest Earnings Report? - The Motley Fool
ISRG stock holds steady as Intuitive Surgical awaits fresh catalyst - Ad-hoc-news.de
ISRG Stock: The Math Hidden In Its Price - Trefis
Medtronic adds real-time AI to Hugo robot - MedTech Dive
Here's How Much $100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth Today - Benzinga
Intuitive Surgical (ISRG) Slid Despite Strong Fundamentals - Yahoo Finance
Intuitive Surgical Stock Is Trading at Multi-Year Lows: Is It a Bargain Buy? - The Motley Fool
Intuitive Surgical stock trades near record levels as procedure growth supports earnings - Ad-hoc-news.de
Intuitive Surgical, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ISRG) 2026-07-20 - Seeking Alpha
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
The Robot Maker’s Paradox - Trefis
What’s More Important For Intuitive Surgical: Today’s Robots Or Tomorrow’s Growth? - Trefis
3 Reasons Growth Investors Will Love Intuitive Surgical (ISRG) - Yahoo Finance
Bernstein cuts Intuitive Surgical stock price target on U.S. growth concerns - Investing.com
Intuitive Surgical Inc Azioni (ISRG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Intuitive Surgical Inc Azioni (ISRG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 12 '26 |
Sale |
414.13 |
25 |
10,353 |
1,406 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 11 '26 |
Sale |
412.16 |
23 |
9,480 |
1,431 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 10 '26 |
Sale |
424.14 |
23 |
9,755 |
1,454 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 09 '26 |
Sale |
421.13 |
23 |
9,686 |
1,477 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha |
Jun 08 '26 |
Sale |
420.12 |
23 |
9,663 |
1,500 |
| LOEB GARY | EVP & Chief Legal and Complian |
Jun 10 '26 |
Sale |
424.14 |
400 |
169,656 |
5,720 |
0.00%
0.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):